Nurlu Temel, E. Et Al. 2023. The β1 Adrenergic Blocker Nebivolol Ameliorates Development of Endotoxic Acute Lung Injury. JOURNAL OF CLINICAL MEDICINE , vol.12, no.5 , 1721-1735.

Nurlu Temel, E., Savran, M., Erzurumlu, Y., Hasseyid, N., & Coşkun Beyan, A., (2023). The β1 Adrenergic Blocker Nebivolol Ameliorates Development of Endotoxic Acute Lung Injury. JOURNAL OF CLINICAL MEDICINE , vol.12, no.5, 1721-1735.

Nurlu Temel, Esra Et Al. "The β1 Adrenergic Blocker Nebivolol Ameliorates Development of Endotoxic Acute Lung Injury," JOURNAL OF CLINICAL MEDICINE , vol.12, no.5, 1721-1735, 2023

Nurlu Temel, Esra N. Et Al. "The β1 Adrenergic Blocker Nebivolol Ameliorates Development of Endotoxic Acute Lung Injury." JOURNAL OF CLINICAL MEDICINE , vol.12, no.5, pp.1721-1735, 2023

Nurlu Temel, E. Et Al. (2023) . "The β1 Adrenergic Blocker Nebivolol Ameliorates Development of Endotoxic Acute Lung Injury." JOURNAL OF CLINICAL MEDICINE , vol.12, no.5, pp.1721-1735.

@article{article, author={Esra Nurlu Temel Et Al. }, title={The β1 Adrenergic Blocker Nebivolol Ameliorates Development of Endotoxic Acute Lung Injury}, journal={JOURNAL OF CLINICAL MEDICINE}, year=2023, pages={1721-1735} }